
- What Is Policybazaar Management Saying About the IRDAI Rules?
- Why Lower Commissions Matter for Policybazaar
- Policybazaar Plans to Slow Hiring and Reduce Marketing Spending
- Can Cost Cuts Really Protect PB Fintech's Profitability?
- Why FY28 Could Become the Real Test for Policybazaar
- Could Policybazaar Eventually Become an Insurance Manufacturer?
- What Other Options Does Policybazaar Have?
- What Should PB Fintech Investors Track Next?
- Author's Take
PB Fintech shares remain under pressure after IRDAI's proposed changes to insurance distribution commissions. But the bigger development now is management's response: Policybazaar is preparing to cut costs, accept slower growth if needed and even reconsider whether it should remain purely an insurance distributor.
The key question for investors is whether these changes can protect profitability if distribution economics permanently weaken.
What Is Policybazaar Management Saying About the IRDAI Rules?
Management has indicated that the biggest pressure could come in non-life insurance. The net present value, or NPV, of parts of this business could fall to roughly 33% to 40% of current levels if the proposals are implemented broadly in their existing form.
This does not mean PB Fintech's overall revenue could fall by 60% to 67%. It means the lifetime economics generated from certain non-life policies could become substantially weaker because Policybazaar may earn lower commissions from them.
Life insurance could be relatively better protected. Management has indicated that changes in the timing of commissions, including renewal commissions in products such as term insurance, could partly compensate for lower upfront payouts.
The regulatory impact therefore appears much larger for parts of health, motor and other general insurance than for PB Fintech as a whole.
Why Lower Commissions Matter for Policybazaar
Policybazaar largely operates an asset-light distribution model. It brings customers and insurers together and earns distribution-related revenue without taking insurance underwriting risk on its own balance sheet.
That makes commission economics particularly important.
If Policybazaar spends ₹100 acquiring and servicing a customer and expects ₹150 of lifetime revenue, the economics are attractive. If regulation reduces that lifetime revenue to ₹100 or ₹110, continuing to spend the same amount acquiring customers becomes much harder to justify.
Policybazaar therefore needs to either lower customer acquisition costs, generate more revenue from existing customers or capture a larger share of the insurance value chain. Management's response suggests it is exploring all three.
Policybazaar Plans to Slow Hiring and Reduce Marketing Spending
The most immediate response is cost control. Management has indicated that PB Fintech could slow hiring and rationalise marketing expenditure if the proposed rules take effect. Policybazaar CEO Sarbvir Singh has also said the company is not planning mass layoffs.
Marketing is an especially important lever. Policybazaar has spent years building brand awareness and acquiring customers. But if the lifetime value of a newly acquired customer falls, spending the same amount to acquire that customer will hurt profitability.
Lower marketing expenditure can help restore that balance. The trade-off is growth. Fewer marketing dollars and slower hiring can protect margins but could also mean fewer leads and slower premium growth.
Management therefore appears willing to accept slower growth rather than spend aggressively on customers whose economics have deteriorated.
Can Cost Cuts Really Protect PB Fintech's Profitability?
PB Fintech entered this regulatory uncertainty while profitability was improving.
In Q1 FY27, consolidated revenue increased 40% year-on-year to ₹1,888 crore while adjusted EBITDA more than doubled to ₹186 crore from ₹89 crore. Profit after tax increased 92% to ₹163 crore and total insurance premium handled through the platform increased 41% to ₹8,372 crore.
The core online business, including Policybazaar and Paisabazaar, generated ₹1,194 crore of revenue and ₹222 crore of adjusted EBITDA. Its adjusted EBITDA margin improved to roughly 19% from 14% a year earlier.
The proposed commission changes threaten this improving operating leverage.
Motilal Oswal estimates that the proposed regulations could reduce PB Fintech's FY28 core online insurance revenue by around 30%. Without meaningful offsets, it estimates the earnings impact could reach around 46%.
If employee and advertising expenses are around 20% below its previous assumptions, the estimated earnings reduction falls closer to 30%.
| Scenario | Motilal Oswal Estimate |
| Potential earnings impact without major offsets | ~46% lower |
| Potential earnings impact after employee and advertising cost reductions | ~30% lower |
These are brokerage estimates and not PB Fintech guidance. The numbers show why management is focusing on costs. Cost reductions can meaningfully soften the earnings impact. But they cannot completely replace lost revenue. That is the limitation of the strategy.
Why FY28 Could Become the Real Test for Policybazaar
Management commentary suggests FY28 could become an adjustment year if the proposed rules are implemented.
The impact may not appear immediately because the regulations first need to be finalised. Insurers and distributors would then need to redesign commission structures and adjust spending.
FY28 could therefore test two things at the same time: how much revenue Policybazaar loses from weaker distribution economics and how much of that pressure it can offset through lower costs.
More importantly, investors will get to see whether premium growth can remain healthy with lower marketing and hiring intensity.
That will tell us whether Policybazaar's existing scale and brand are strong enough to generate growth without the same level of incremental spending.
Could Policybazaar Eventually Become an Insurance Manufacturer?
This may be the most important part of management's commentary.
PB Fintech co-founder and Group CEO Yashish Dahiya has indicated that weaker distribution economics could make insurance manufacturing more attractive to Policybazaar. That would be a significant strategic shift.
Today, Policybazaar acquires customers and facilitates insurance purchases while insurers design products, price risk and ultimately carry the claims liability.
If Policybazaar eventually participates in insurance manufacturing, it could capture a larger portion of the economics generated by customers already coming through its platform.
The scale is meaningful. As of June 2026, PB Fintech said its platforms had sold 71.6 million insurance policies while its India insurance premium run rate was around ₹35,500 crore annually.
That distribution network could become a significant advantage if Policybazaar moves further into the insurance value chain.
But manufacturing insurance is fundamentally different from distributing it.
An insurer needs regulatory capital, must maintain solvency and reserves and ultimately takes underwriting and claims risk. That would make PB Fintech more capital-intensive and financially complex than its existing asset-light model.
So becoming an insurer cannot automatically be treated as a positive. The real question is whether the additional economics Policybazaar could capture would justify the additional capital and underwriting risk.
What Other Options Does Policybazaar Have?
Insurance manufacturing is not the only possible response. Management and brokerage commentary have also pointed towards opportunities such as managing general agent structures, credit-life products and greater monetisation of businesses such as PB Wheels and PB Garages.
The broader strategy would be to earn more from customers already acquired through the Policybazaar ecosystem.
That could reduce PB Fintech's dependence on commission economics in any single insurance category. But there is an important difference in timing.
Marketing cuts and slower hiring can be implemented relatively quickly. New businesses and insurance manufacturing can take much longer and may require regulatory approvals, capital and execution.
They should therefore be viewed as potential longer-term responses rather than immediate solutions to lower commissions.
What Should PB Fintech Investors Track Next?
- Final IRDAI regulations: The financial impact ultimately depends on the final commission limits, product-level rules and implementation timeline.
- Non-life economics: Management's indication that the NPV of affected non-life products could fall to around 33% to 40% of current levels remains one of the most important numbers.
- Marketing efficiency: Investors should watch whether Policybazaar can reduce acquisition spending without materially weakening premium growth.
- FY28 profitability: The balance between lower revenue and cost reductions will show how flexible PB Fintech's model really is.
- Insurance manufacturing: Any concrete step towards becoming or investing in an insurer would materially change PB Fintech's capital requirements and business model.
Author's Take
PB Fintech's immediate response makes financial sense. If every new insurance customer becomes less valuable, Policybazaar should not continue spending the same amount to acquire that customer simply to protect growth.
Slower hiring and lower marketing can protect profitability, but there is a limit to how much costs can be reduced without affecting growth.
That makes Yashish Dahiya's comments about insurance manufacturing particularly important. If distribution economics permanently weaken, Policybazaar may eventually need to earn more from each customer rather than simply cut what it spends to acquire them.
The IRDAI proposals could therefore do more than reduce PB Fintech's commissions. They could force management to reconsider where Policybazaar should sit in the insurance value chain.